The relative benefits of claims and electronic health record data for predicting medication adherence trajectory

Am Heart J. 2018 Mar:197:153-162. doi: 10.1016/j.ahj.2017.09.019. Epub 2017 Dec 2.

Abstract

Background: Healthcare providers are increasingly encouraged to improve their patients' adherence to chronic disease medications. Prediction of adherence can identify patients in need of intervention, but most prediction efforts have focused on claims data, which may be unavailable to providers. Electronic health records (EHR) are readily available and may provide richer information with which to predict adherence than is currently available through claims.

Methods: In a linked database of complete Medicare Advantage claims and comprehensive EHR from a multi-specialty outpatient practice, we identified patients who filled a prescription for a statin, antihypertensive, or oral antidiabetic during 2011 to 2012. We followed patients to identify subsequent medication filling patterns and used group-based trajectory models to assign patients to adherence trajectories. We then identified potential predictors from both claims and EHR data and fit a series of models to evaluate the accuracy of each data source in predicting medication adherence.

Results: Claims were highly predictive of patients in the worst adherence trajectory (C=0.78), but EHR data also provided good predictions (C=0.72). Among claims predictors, presence of a prior gap in filling of at least 6 days was by far the most influential predictor. In contrast, good predictions from EHR data required complex models with many variables.

Conclusion: EHR data can provide good predictions of adherence trajectory and therefore may be useful for providers seeking to deploy resource-intensive interventions. However, prior adherence information derived from claims is most predictive, and can supplement EHR data when it is available.

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Chronic Disease / drug therapy*
  • Electronic Health Records / statistics & numerical data*
  • Evidence-Based Practice / methods
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypoglycemic Agents / therapeutic use*
  • Insurance Claim Review*
  • Male
  • Medicare / statistics & numerical data
  • Medication Adherence / statistics & numerical data*
  • Needs Assessment
  • Outpatients / statistics & numerical data
  • United States

Substances

  • Antihypertensive Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypoglycemic Agents